Valuation: BICO Group AB

Market Cap 109.96Cr 11Cr 9.88Cr 9.13Cr 8.23Cr 16Cr 1.02TCr 16Cr 43Cr 548.61Cr 41Cr 40Cr 1.73TCr P/E 2026 *
-2.82x
P/E 2027 * -7.87x
Enterprise Value 109.26Cr 11Cr 9.82Cr 9.07Cr 8.18Cr 15Cr 1.01TCr 16Cr 43Cr 545.12Cr 41Cr 40Cr 1.72TCr EV / Sales 2026 *
0.69x
EV / Sales 2027 * 0.65x
Free-Float
69.88%
Yield 2026 *
-
Yield 2027 * -
1 day-22.63%
1 week-22.63%
Current month-22.37%
1 month-32.46%
3 months+29.45%
6 months-26.55%
Current year-14.06%
1 week 0.48
Extreme 0.4774
0.48
1 month 0.48
Extreme 0.4774
0.67
Current year 0.35
Extreme 0.35
0.71
1 year 0.35
Extreme 0.35
0.71
3 years 0.35
Extreme 0.35
1.55
5 years 0.35
Extreme 0.35
10.56
10 years 0.35
Extreme 0.35
14.8
Manager TitleAgeSince
Chief Executive Officer 51 01/09/2026
Director of Finance/CFO 56 01/03/2026
Chief Operating Officer - 07/01/2026
Director TitleAgeSince
Director/Board Member 71 18/12/2019
Director/Board Member 37 01/03/2015
Director/Board Member 51 07/05/2026
Change 5-day change 1-year change 3-year change Capi.($)
-22.63%-22.63% - - 11Cr
-0.13%-3.98%+21.59%+47.86% 26TCr
-1.05%-3.97%+2.85%+9.12% 16TCr
-1.26%-4.00%-20.97%+41.53% 15TCr
-1.01%-3.39%-57.56%-20.53% 6.33TCr
-0.57%+2.66%+26.01%+59.61% 6.16TCr
-1.59%+0.84%+3.64%-13.47% 5.39TCr
+0.02%-2.93%+19.48%+52.61% 4.88TCr
-1.60%-4.02%+5.87%+66.12% 4.85TCr
-0.50%-5.11%+19.37%+72.30% 4.46TCr
Average -3.03%-0.29%+2.25%+35.02% 10TCr
Weighted average by Cap. -0.74%-0.31%+3.44%+34.46%

Financials

2026 *2027 *
Net sales 158.04Cr 16Cr 14Cr 13Cr 12Cr 22Cr 1.46TCr 23Cr 63Cr 788.49Cr 59Cr 57Cr 2.49TCr 157.88Cr 16Cr 14Cr 13Cr 12Cr 22Cr 1.46TCr 23Cr 62Cr 787.7Cr 59Cr 57Cr 2.49TCr
Net income -39Cr -3.86Cr -3.51Cr -3.24Cr -2.92Cr -5.52Cr -360.93Cr -5.73Cr -15Cr -194.76Cr -14Cr -14Cr -615.34Cr -9.53Cr -94.31L -85.62L -79.09L -71.35L -1.35Cr -88Cr -1.4Cr -3.77Cr -48Cr -3.54Cr -3.46Cr -150.23Cr
Net Debt -70L -7L -6L -6L -5L -10L -6.47Cr -10.27L -27.69L -3.49Cr -25.99L -25.44L -11Cr -7.2Cr -71.25L -64.68L -59.75L -53.91L -1.02Cr -67Cr -1.06Cr -2.85Cr -36Cr -2.67Cr -2.62Cr -113.5Cr
Projected Income Statement - Annual - BICO Group AB
Logo BICO Group AB
BICO Group AB, previously Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Company develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.
Employees
554
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - BICO Group AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
15.58SEK
Average target price
31.50SEK
Spread / Average Target
+102.18%